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Summary
Two-Partner Secretion (TPS) systems use β-barrel proteins of the Omp85-TpsB superfamily to
transport large exoproteins across the outer membranes of Gram-negative bacteria. The Bordetella
FHA/FhaC proteins are prototypical of TPS systems in which the exoprotein contains a large C-
terminal prodomain that is removed during translocation. Although it is known that the FhaB
prodomain is required for FHA function in vivo, its role in FHA maturation has remained
mysterious. We show here that the FhaB prodomain is required for the extracellularly-located
mature C-terminal domain (MCD) of FHA to achieve its proper conformation. We show that the
C-terminus of the prodomain is retained intracellularly and that sequences within the N-terminus
of the prodomain are required for this intracellular localization. We also identify sequences at the
C-terminus of the MCD that are required for release of mature FHA from the cell surface. Our
data support a model in which the intracellularly-located prodomain affects the final conformation
of the extracellularly-located MCD, which, we hypothesize, triggers cleavage and degradation of
the prodomain.
Introduction
Two Partner Secretion (TPS) systems are widespread amongst Gram-negative bacteria. They
use β-barrel, channel-forming proteins (TpsB family members) to translocate large,
predominantly β-helical, exoproteins (TpsA family members) across the outer membrane to
the cell surface (Mazar and Cotter, 2007; Jacob-Dubuisson et al., 2009). TpsA family
members include adhesins, such as filamentous hemagglutinin (FHA) of Bordetella species
and the HMW proteins of Haemophilus influenzae; cytolysins, such as ShlA of Serratia
marcescens; and contact dependent growth inhibition (CDI) mediators, such as CdiA of
Escherichia coli (Jacob-Dubuisson et al., 2004; Aoki et al., 2005). TpsB proteins are
members of the Omp85-TpsB superfamily, which includes BamA, the main component of
the Bam complex that inserts β-barrel proteins into the outer membranes of Gram-negative
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bacteria (Genevrois et al., 2003; Voulhoux et al., 2003; Wu et al., 2005; Hagan et al., 2011),
and also Tob55/Sam50 and Toc75, which insert proteins into the outer membranes of
mitochondria and chloroplasts, respectively (Reumann and Keegstra, 1999; Kozjak et al.,
2003). Used by bacteria and organelles of fungi, plants, and animals, protein translocation
by the Omp85-TpsB superfamily is the most widely distributed outer membrane protein
secretion mechanism known (Yen et al., 2002).
Omp85-TpsB family members are composed of soluble N-terminal regions containing one
to five polypeptide transport associated (POTRA) domains and C-terminal regions of about
350 aa that form a transmembrane β-barrel. The Bordetella pertussis TpsB family member
FhaC has been crystallized and its structure solved with 3.15 Å resolution (Clantin et al.,
2007). Sequence comparisons of bacterial TpsB proteins indicate that they can be separated
into at least four distinct subfamilies, with FhaC, HMW1B (which exports H. influenzae
HMW1), ShlB (which exports S. marcescens ShlA), and CdiB (which exports E. coli CdiA)
representing the best characterized member of each subfamily.
TpsA family members are less well conserved. Their amino acid similarity is greatest within
an ~250 aa region at the N-terminus called the “TPS domain” (Jacob-Dubuisson et al.,
2004). The TPS domains of Bordetella FHA and H. influenzae HMW1 are required for
secretion and each has been shown to be sufficient, as a polypeptide fragment, for
translocation by their cognate TpsB protein when produced in E. coli (Renauld-Mongenie et
al., 1996; Grass and St Geme, 2000). The TPS domain of FHA has been shown to interact
with the POTRA domains of FhaC and to do so in an unfolded state (Hodak et al., 2006).
Although they share less amino acid sequence similarity in regions C-terminal to the TPS
domains, all TpsA proteins are predicted to contain a substantial amount of β-helical
character, the folding of which has been hypothesized to provide the energy for translocation
across the outer membrane (Thanassi et al., 2005). Comparison of the amino acid sequences
of TPS domains separates TpsA proteins into the same four subfamilies identified by
comparison of TpsB family members, and the different subfamilies appear to correlate with
different TpsA biogenesis processes. For example, HMW1 contains a N-terminal “pro-
piece” that is removed during outer membrane translocation and mature HMW1 is anchored
to the cell surface by its C-terminus (Grass and St Geme, 2000; Buscher et al., 2006). FHA,
by contrast, is synthesized with a C-terminal prodomain that is ultimately removed and
mature FHA is anchored to the cell via its N-terminus (Renauld-Mongenie et al., 1996;
Mazar and Cotter, 2006). In the case of CdiA, there appears to be no pro-peptide processing
(other than removal of the signal sequence) and given the C-terminal location of the toxic
domain, it is assumed that the protein is anchored via its N-terminus (Aoki et al., 2010;
Hayes et al., 2010). Similarly, ShlA also does not have an evident pro-peptide, and a C-
terminal pore-forming effector domain suggests that ShlA is surface-associated by its N-
terminus (Hertle, 2005).
FHA is one of the primary virulence factors produced by B. pertussis, the causative agent of
whooping cough, and the closely related, broad host-range pathogen, B. bronchiseptica.
FHA mediates adherence to epithelial cells and macrophages in vitro and is required for
tracheal colonization in vivo (Urisu et al., 1986; Locht et al., 1993; Cotter et al., 1998;
Inatsuka et al., 2005; Julio et al., 2009). FHA also modulates the inflammatory response to
infection, contributing to persistence in the lower respiratory tract (Inatsuka et al., 2005;
Henderson et al., 2012), and FHA is one of the primary components of acellular pertussis
vaccines (Sato and Sato, 1999). As one of the best-studied TPS pathways, FHA/FhaC is one
of the primary models used for understanding the TPS mechanism.
The current model for FHA secretion is shown in Supplemental Figure 1A. FHA is initially
synthesized as an ~375 kDa preproprotein called FhaB. FhaB contains a 71 aa signal
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peptide, which includes an N-terminal extension of 21 residues, that targets the protein to
the general secretory machinery in a SecAB-dependent, post-translational manner (Lambert-
Buisine et al., 1998; Chevalier et al., 2004; Desvaux et al., 2007). The N-terminal TPS
domain associates with the periplasmic POTRA domains of FhaC to initiate outer membrane
translocation (Sanchez-Pulido et al., 2003; Hodak et al., 2006). Translocation through FhaC
is thought to initiate with an extended hairpin forming through the FhaC channel, then the
C-terminus of the TPS domain folds into a β-helix as it emerges on the cell surface. As more
residues reach the surface, they continue to adopt a right-handed β-helical fold, starting from
the cell surface and folding outward to a length of ~35 nm (Makhov et al., 1994; Kajava et
al., 2001; Clantin et al., 2004). C-terminal to the β-helical shaft is a domain of poor
structural definition that becomes the mature C-terminal domain (MCD) of FHA, which is
critical for FHA function in vivo and in vitro (Mazar and Cotter, 2006; Julio et al., 2009).
Cleavage of FhaB occurs C-terminal to the MCD, yielding the ~250 kDa mature FHA
protein. The autotransporter SphB1 is required for cleavage of FhaB somewhere within a
PLFETRIKFID sequence (residues 2472–2482 of B. bronchiseptica and 2362–2372 of B.
pertussis) and at least one site ~100 aa N-terminal to this sequence, although SphB1 has not
been shown to cleave FhaB directly (Coutte et al., 2001). One or more unidentified proteases
are also involved in FHA maturation, as FhaB is processed to a slightly larger protein,
referred to as FHA* in B. pertussis or FHA’ in B. bronchiseptica, in sphB1 deletion strains
(Coutte et al., 2001; Mazar and Cotter, 2006). The C-terminus of FHA’ in B. bronchiseptica
strain RB50 is located between residues 2485 and 2545 (Mazar and Cotter, 2006). Although
mature FHA can be detected on the cell surface with its C-terminus facing outward, a
substantial amount is released into the extracellular environment. Neither the mechanism
controlling surface retention versus release nor the biological relevance of FHA release is
known.
The C-terminal ~1200 aa prodomain of FhaB is not detectable after SphB1-dependent or
SphB1-independent cleavage and is thought to be rapidly degraded (Delisse-Gathoye et al.,
1990; Mazar and Cotter, 2006). Although models for FhaB secretion and maturation have
suggested that the prodomain remains in an intracellular compartment (Renauld-Mongenie
et al., 1996; Mazar and Cotter, 2007), its fate is unknown and it is possible that it functions
from the cell surface (Supplemental Figure 1B and C, respectively). B. bronchiseptica and
B. pertussis strains in which FhaB is synthesized with truncated prodomains produce FHA
proteins that appear to be translocated to the cell surface, processed in an SphB1-dependent
manner, and released into the extracellular environment, yet these strains are defective for
adherence to epithelial cells and macrophages in vitro and, in the case of B. bronchiseptica,
for tracheal colonization in vivo (Mazar and Cotter, 2006). The goal of this work was to
determine the role of the FhaB prodomain in maturation and function of FHA.
Results
Bioinformatic analysis of the FhaB prodomain
A PSI-BLAST search using the entire B. bronchiseptica FhaB prodomain as query revealed
substantial similarity over the entire length of the prodomain (E values ≤ e−30) with other
FHA-related proteins in Bordetella species as well as a few related proteins in Pasteurella
multocida, Haemophilus ducreyi, Citrobacter rodentium, and Erwinia billingiae. Strikingly,
however, hundreds of predicted TpsA proteins, many of which are known to belong to the
FHA subfamily, were identified with significant similarity (alignment scores between 80
and 200) to residues 2772–2601 of the FhaB prodomain, which we are now calling the
prodomain N-terminus (PNT). ClustalW analysis revealed ~50% similarity overall amongst
the proteins identified in our analysis (Supplemental Figure 2). No similarity with other
proteins above the threshold level set by PSI-BLAST was identified for regions of the FhaB
prodomain C-terminal to the PNT. We did, however, notice a proline rich region near the C-
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terminus of the prodomain by simple visual examination of the amino acid sequence. This
proline rich region has been noted previously (Locht et al., 1992) and, curiously, a putative
FHA ortholog in Bordetella avium contains a region with even more prolines near its C-
terminus. There are no reports of functional characterization for any sequences with which
similarity with the prodomain was identified.
The FhaB prodomain is required for the MCD to attain its proper conformation
Because the prodomain is required for FHA function in vivo (Mazar and Cotter, 2006) and
there is evidence that the MCD is an important functional domain (Julio et al., 2009;
Henderson et al., 2012), we hypothesized that the FhaB prodomain is required for the MCD
to attain its proper conformation. To test this hypothesis, two B. pertussis strains were
constructed that produce FhaB proteins containing hexahistidine (His6) insertions
immediately C-terminal to Q72 (the N-terminal amino acid of mature FHA) and tobacco
etch virus (TEV) protease cleavage sites at the junction between the β-helical shaft and the
MCD. One strain (BPSMAQ) produced full-length FhaB and the other (BPSMAQT-N)
contained a stop codon in fhaB 106 codons 3’ to the region encoding the primary SphB1-
dependent cleavage site (Figure 1A–note that residue numbering of the schematic
corresponds to B. pertussis FhaB, not B. bronchiseptica FhaB). We used B. pertussis strain
BPSM for these experiments because it releases substantially more FHA into culture
supernatants than B. bronchiseptica strain RB50, facilitating our ability to recover a
sufficient amount of protein with minimal manipulation (Jacob-Dubuisson et al., 2000;
Mazar and Cotter, 2006). The presence of the His6 tag and the TEV protease cleavage site
did not affect the ability of otherwise wildtype FHA to function as an adhesin in vitro
(Figure 1B). Bacteria were grown under fhaB-inducing conditions, and culture supernatants
were collected under native conditions and incubated with nickel-chelating resin, which was
then washed and incubated with AcTEV protease to release the MCD from FHA. The MCD
polypeptides were resolved on a semi-native polyacrylamide gel (0.6% SDS). Samples were
then transferred to a nitrocellulose membrane and probed with anti-MCD antibody. The
MCD polypeptides recovered from the BPSMAQ and BPSMAQT-N strains under native
conditions migrated with different mobilities on the semi-native gel, but they migrated with
the same mobility after heat denaturation (Figure 1C). The MCD polypeptides migrated with
the same mobility regardless of pre-heating when separated by standard, denaturing, SDS-
PAGE (2.0% SDS). These results suggest that the presence of the prodomain in the nascent
FhaB polypeptide affects the conformation of the MCD in mature FHA.
We also treated the native MCD polypeptides with increasing concentrations of proteinase-
K and resolved them by SDS-PAGE. While the MCD from BPSMAQ (which produces full-
length FhaB) was completely digested by 12 μg/mL of proteinase-K, 50 μg/mL of
proteinase-K was required to completely degrade the MCD from BPSMAQT-N (Figure 1D).
As a control, the MCDs from both strains were boiled to denature the proteins, then allowed
to renature, and were then incubated with proteinase-K. After being subjected to denaturing
and renaturing conditions in vitro, both MCD polypeptides were completely degraded by 25
μg/mL proteinase-K, suggesting that the conformations of the in vitro renatured proteins
were the same (but different from those of the naturally folded polypeptides, which were
digested by either 25 or 50 μg/mL proteinase-K). Together, these data indicate that the
conformation of the MCD that forms after translocation to the bacterial surface differs
depending on whether the initially synthesized FhaB protein contains the C-terminal
prodomain.
As an additional approach to probe the conformation of the MCD, we performed cysteine-
accessibility experiments, taking advantage of the fact that FHA contains no cysteine
residues. We constructed a series of B. bronchiseptica strains – in both wildtype (WT) and
prodomain-truncated (ΔPD) backgrounds – in which a single codon in the MCD-encoding
Noël et al. Page 4













region of fhaB was changed to a cysteine codon (Figure 2A), with substitutions regularly
spaced ~50 aa apart. (We used B. bronchiseptica for these experiments so that the mutant
strains could subsequently be compared with wildtype bacteria for their ability to establish
respiratory infections in natural-host animal models.) The strains shown in Figure 2 are
those that grew and adhered to L2 rat lung epithelial cells in a manner indistinguishable
from wildtype B. bronchiseptica (data not shown) and they released FHA as efficiently as
wildtype bacteria. Culture supernatants were concentrated under native conditions and
incubated with DyLight 680 Maleimide, which forms a covalent bond with the sulfhydryl
group on cysteine residues. Samples were then separated by SDS-PAGE, transferred to a
nitrocellulose membrane, and probed with an antibody that recognizes a central region of
FHA (the carbohydrate recognition domain (CRD)) to determine the relative amounts of
FHA contained in each sample. The anti-CRD antibody was detected with anti-chicken
antibody conjugated to a near-infrared dye that fluoresces at 800 nm, shown in green in
Figure 2B. The fluorophore of the DyLight 680 Maleimide fluoresces at 680 nm, shown in
red in Figure 1D. For the A2382C substitution, and to a lesser extent, the A2432C
substitution, FHA produced in the wildtype strain displayed greater DyLight-dependent
fluorescence than FHA produced in the ΔPD strain, indicating that these cysteines were
more accessible in the FHA produced by the wildtype strain than in the FHA produced by
the ΔPD strain (Figure 2B). Conversely, for the V2081C, L2284C and I2233C substitutions,
FHA produced by the wildtype strain displayed weaker fluorescence than FHA produced by
the ΔPD strain. These data indicate that the accessibility of the cysteine residues differed
depending on whether FhaB contained an intact prodomain and therefore provide further
support for the conclusion that the prodomain affects the conformation of the MCD.
The C-terminus of the prodomain remains in an intracellular compartment
We envisaged three mechanisms by which the FhaB prodomain could affect the
conformation of the MCD on mature FHA: 1) the prodomain could function as a scaffold or
‘foldase’ for the MCD, analogous to the prodomains of many secreted proteases of Gram-
positive bacteria (Shinde and Thomas, 2011); 2) the prodomain could remain in an
intracellular compartment, functioning as a tether to constrain the possible conformations
that the MCD can sample before attaining a stably folded state; 3) the prodomain could
control the rate of translocation of the MCD to the cell surface and that controlled
translocation could be required for proper folding (e.g., perhaps the N-terminal region needs
to fold first, followed by the C-terminal region). In the first mechanism, the entire
prodomain would be translocated to the cell surface before subsequent maturation (assuming
that a fully folded MCD cannot be translocated through FhaC) while in the second and third
mechanisms, the C-terminus of the prodomain would remain in an intracellular
compartment. We therefore sought to determine the location of the prodomain during
maturation of FHA. We were specifically interested in determining the location of the C-
terminus of the prodomain before cleavage of FhaB to form FHA.
We first constructed a B. bronchiseptica strain (CTHA) producing FhaB with a
hemagglutinin (HA) epitope seven residues N-terminal to the C-terminus of FhaB
(Supplemental Figure 3A). Immunoblot analysis indicated that the HA epitope disrupted the
stability of full-length FhaB (no full-length FhaB protein was detected in this strain by either
the anti-MCD or anti-HA antibodies (Supplemental Figure 3B)), rendering the strain
unsuitable for localization studies. We therefore constructed a B. bronchiseptica strain
(HAPRR) producing FhaB with an HA epitope after residue 3265, just N-terminal to the
proline-rich region in the FhaB prodomain (Supplemental Figure 3A). This epitope did not
affect secretion, maturation, or release of FhaB, as the proportion of FhaB and FHA
polypeptides was indistinguishable between this strain and wildtype bacteria (Supplemental
Figure 3B). Moreover, preliminary data suggest this strain is indistinguishable from
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wildtype B. bronchiseptica in its ability to cause respiratory infection in mice (our
unpublished results).
To determine if the prodomain remains in an intracellular location, the HAPRR strain was
grown under FHA-inducing conditions, cells were harvested by centrifugation and
suspended in buffer with 1 μg/mL proteinase-K to cleave surface-exposed proteins, washed
to remove extracellular protein fragments, then whole-cell lysates (WCLs) were prepared
and analyzed by immunoblot (Figure 3B. Note that the left and right panels in Figure 3B are
the same immunoblot. The intensity of the red channel was increased in the panel on the
right to facilitate visualization of polypeptides detected by the anti-HA antibody. Similar
manipulation of the green channel did not reveal any additional bands). In the untreated
sample, full-length, unprocessed FhaB (~375 kDa) was detected by both anti-MCD and anti-
HA antibodies and mature FHA (FHA and FHA’, ~250 kDa) was detected by only the anti-
MCD antibody. Some polypeptides of ~200 kDa were also detected by the anti-HA antibody
(evident in the right panel), suggesting they result from proteolysis near the N-terminus of
FhaB. Since FHA is anchored to the cell surface by its N-terminus, we hypothesize that
these polypeptides result from proteolysis during sample preparation. Consistent with
previous results indicating that the prodomain is degraded rapidly after FhaB processing
(Delisse-Gathoye et al., 1990; Mazar and Cotter, 2006), no polypeptide of ~130 kDa was
recognized by the anti-HA antibody in the untreated samples. Proteinase-K treatment caused
a decrease in the amount of full-length FhaB (and mature FHA) and PMSF inhibited this
proteolysis, indicating that this proteolysis was proteinase-K-dependent. Concomitant with
the proteinase-K-dependent decrease in FhaB was the appearance of polypeptides of ~230
kDa that were recognized by only the anti-MCD antibody (green channel) and polypeptides
of ~120–140 kDa that were recognized by only the anti-HA antibody (Figure 3B, red
channel in the right panel). Proteinase-K activity was confined to the extracellular space, as
indicated by the integrity of BvgS, a sensor kinase that spans the cytoplasmic membrane and
contains a large periplasmic domain. The ~230 kDa polypeptide that predominates after
proteinase-K treatment is most likely the N-terminus and β-helical shaft region of FHA,
consistent with β-helical proteins’ resistance to proteinase-K (Ieva and Bernstein, 2009;
Junker et al., 2009). The appearance of cell-associated HA-containing polypeptides of ~120–
140 kDa after proteinase-K treatment, but not before proteinase-K treatment, indicates that
they arose from polypeptides in which the C-terminus of the prodomain was intracellular
while the central region of FhaB (most of the β-helical shaft, the MCD, and perhaps the N-
terminus of the prodomain) was extracellular. In the ΔsphB1 strain, more polypeptides in
the range of ~120–160 kDa were recognized by the anti-HA antibody in the proteinase-K
treated sample than in the proteinase-K treated sample of the strain that is wildtype for
sphB1 (Figure 3B, right). These data suggest that the C-terminus of the prodomain remains
in an intracellular compartment during outer membrane translocation of the β-helix and
MCD regions, but these data cannot distinguish between periplasmic versus cytoplasmic
localization of the prodomain C-terminus.
The region surrounding FhaB maturation sites is required for the C-terminus of the
prodomain to remain in an intracellular compartment and for mature FHA to be released
from the cell surface
Although the data shown in Figure 3 suggest an intracellular location for the FhaB
prodomain, the experiment is complicated by the fact that FhaB is processed by both SphB1
and one or more unidentified proteases, making it difficult to ‘capture’ the pre-cleavage
FhaB secretion intermediate. In an attempt to eliminate both SphB1-dependent and SphB1-
independent processing, we constructed a strain (HA-ΔCS) producing an FhaB protein with
a 431 aa deletion encompassing the known SphB1-dependent cleavage sites and the region
that becomes the C-terminus of FHA’, which is produced by cleavage/degradation by the
Noël et al. Page 6













unidentified protease(s). The FhaB produced by this strain contains an HA epitope N-
terminal to the PRR, the same as in the HAPRR strain (Figure 4A). Unprocessed FhaB in
the HA-ΔCS strain was smaller than FhaB in wildtype bacteria (consistent with the size of
the deletion) and was detected with both anti-MCD and anti-HA antibodies (Figure 4B, band
5. Illustrations to the right of Figure 4B illustrate how we envision FhaB/FHA exist on the
cell surface with and without proteinase-K treatment. Band numbers on the Western blot
correspond to illustration numbers). Unexpectedly, FhaB was still processed in this strain,
resulting in the formation of polypeptides of ~250 and ~220 kDa (Figure 4B, bands 6
(green)) that were detected only by the anti-MCD antibody and therefore represent the N-
terminal ~2300–2500 aa of FhaB. Processing to form these polypeptides did not occur in a
strain that was isogenic except for deletion of sphB1 (referred to as HA-ΔCS,ΔsphB1),
indicating that the processing was SphB1-dependent (Figure 4B). (Note, however, that this
strain contained an increased amount of FhaB in WCL and many breakdown products were
present that were recognized by the anti-HA antibody and therefore resulted from
degradation from the N-terminus of FhaB, presumably during sample preparation.)
Proteinase-K treatment of the HA-ΔCS strain resulted in cleavage of FhaB and FHA (Figure
4B, band 7), but no polypeptides recognized by the anti-HA antibody were generated that
could be detected in WCL. This result suggested that, in contrast to the case with wildtype
bacteria, the C-terminus of the prodomain was not retained intracellularly in the HA-ΔCS
strain. Comparison of proteins present in culture supernatants showed that wildtype and
ΔsphB1 bacteria released FHA and FHA’, respectively, and did not release HA-containing
polypeptides into the extracellular environment (Figure 4C). By contrast, the HA-ΔCS strain
released a large amount of HA-containing polypeptides of about 50–80 kDa, but released no
mature FHA into the culture supernatant. (Proteins were separated using an 8%
polyacrylamide gel for the immunoblot shown in Figure 4C, which allows lower molecular
weight proteins to be visualized, but limits resolution of higher molecular weight proteins.)
The prodomain, therefore, appears to not be retained intracellularly in the HA-ΔCS strain
and not only are prodomain polypeptides released into the culture supernatant, they are
relatively stable. In the HA-ΔCS,ΔsphB1 strain, FhaB remained predominantly
unprocessed, as WCL contained mostly full-length FhaB and several breakdown products,
but no polypeptides corresponding to FHA. Proteinase-K treatment of the HA-ΔCS,ΔsphB1
strain resulted in the formation of a predominant polypeptide of about 220 kDa that was
recognized by the anti-MCD antibody but not the anti-HA antibody (Figure 4B, band 9),
therefore corresponding to the β-helical shaft and part of the MCD. No HA-containing
polypeptides were released into the culture supernatant of the HA-ΔCS,ΔsphB1 strain,
consistent with the conclusion that processing of FhaB does not occur in this strain and that
the HA-containing polypeptides present in the supernatants of the HA-ΔCS strain were
extracellularly located prodomain fragments released after SphB1-dependent processing.
Together, these data indicate that sequences within the region deleted in the HA-ΔCS strain
are required for retention of the C-terminal region of the prodomain in an intracellular
compartment and are also required for release of mature FHA into the extracellular
environment. Although some degradation of BvgS by proteinase-K was evident in this
experiment, indicating that some amount of proteinase-K entered the cells, the presence of
large amounts of HA-stained polypeptides of ~75 kDa in supernatants of the HA-ΔCS
strain, but no HA-containing polypeptides in supernatants of wildtype B. bronchiseptica,
strongly suggests that the prodomain is retained in an intracellular compartment in wildtype
bacteria but not in HA-ΔCS bacteria. Complete elimination of HA-containing polypeptides
in the HA-ΔCS,ΔsphB1 strain after proteinase-K treatment also supports this conclusion.
As an alternate approach, we performed dot blots of the HAPRR and HA-ΔCS strains
(Figure 5). Whole cells in PBS were applied to a nitrocellulose membrane for detection of
surface antigens and boiled lysates were applied to the membrane for detection of total
cellular protein content. Whole cells of the HAPRR strains (sphB1WT and ΔsphB1
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backgrounds) were stained by only the anti-MCD antibody (Figure 5B; note that the
schematics below the dot blots indicate only the various polypeptide species, not their
relative abundances). Boiling the samples however, allowed detection by both the anti-MCD
and anti-HA antibodies, indicating that the C-terminus of the prodomain in the HAPRR
strains was located intracellularly. In the HA-ΔCS strain (sphB1WT), there was no surface
detection of HA epitopes, consistent with the previous result indicating SphB1-dependent
cleavage and release of a surface-localized prodomain in this strain. Boiling the sample
resulted in weak detection of the HA tag, which we hypothesize represents FhaB molecules
prior to translocation across the outer membrane. In the HA-ΔCS,ΔsphB1 strain, detection
of both surface proteins and cell lysate revealed MCD and HA epitopes, consistent with idea
that the prodomain crossed the outer membrane, but was not cleaved in the absence of
SphB1. (Note: The western blot in Fig. 4B indicates that some full-length, surface-exposed
FhaB is present in the HA- CS,sphB1WT strain (band 5). Although very faint staining of this
strain by the anti-HA antibody was apparent in some dot blot experiments, it is not apparent
in the one shown in Fig. 5B. Lack of significant staining by dot blot compared to western
blot may be due to differences in sample preparation and differences in sensitivity of the two
assays.) As a control, a B. bronchiseptica strain without an HA tag in FhaB (RBX11) was
used in an identical experiment. Although both whole cells and boiled lysates were
recognized by the anti-MCD antibody, neither were recognized by the anti-HA antibody
(Supplemental Figure 4B), demonstrating that there was no nonspecific fluorescence in our
samples probed with the anti-HA antibody. Taken together, these data indicate that the C-
terminus of the prodomain is retained in an intracellular compartment (either the periplasm
or the cytoplasm) during translocation and maturation of FHA and that the prodomain is
degraded rapidly after SphB1-dependent and/or SphB1-independent processing when
retained intracellularly. Sequences within the region deleted in the HA-ΔCS strain are
required for the C-terminus of the prodomain to remain intracellular and for mature FHA to
be released from the cell surface.
The C-terminus of the MCD controls FHA release competency while the N- terminus of the
prodomain controls intracellular prodomain retention
To investigate which sequences within the region deleted in the HA-ΔCS strain were
responsible for retention of the prodomain in an intracellular compartment and for release of
mature FHA, we constructed strains producing FhaB proteins with either a 255 aa deletion
of the MCD C-terminus (the MCT, shaded dark green in Figure 6) or a 176 aa deletion of
the prodomain N-terminus (the PNT, shaded dark red). These strains, which contain the
sequence encoding an HA epitope just 5’ to the PRR-encoding region, were named HA-
ΔMCT and HA-ΔPNT, respectively. The ΔPNT deletion encompasses the primary SphB1-
dependent cleavage site (the sequence of which is PLFETRIKFID).
Immunoblot analysis (resolved by 5% polyacrylamide SDS-PAGE) showed that both
unprocessed and processed FhaB/FHA polypeptides were detectable in WCL of the HA-
ΔMCT strain (Figure 6B, bands 8 and 9, respectively. Bands of the Western blot and
illustration are labeled as in Figure 4B). In addition, a polypeptide of ~150 kDa that was
recognized by both anti-MCD and anti-HA antibodies (Figure 6B, band 10), as well as a few
slightly smaller polypeptides, were detected. Recognition of the ~150 kDa polypeptide by
both antibodies indicates that it includes the prodomain and at least part of the MCD. These
polypeptides were not detected in WCL of the HA-ΔMCT strain that also contained the
ΔsphB1 deletion, demonstrating that they resulted from SphB1-dependent cleavage. The
fact that analogous polypeptides are not present in the HAPRR strain suggests that SphB1-
independent cleavage/degradation is inefficient in the HA-ΔMCT strain, since SphB1-
independent cleavage would have separated the MCD part of the polypeptide from the C-
terminus. The presence of these polypeptides in WCL, but not in supernatants (Figure 6C;
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proteins in culture supernatants were resolved using an 8% polyacrylamide gel, allowing
lower molecular weight proteins to be visualized at the expense of separating higher
molecular weight proteins), also indicates that the C-terminus of the prodomain is present in
an intracellular compartment in this strain as these polypeptides would have been released
into the supernatant fraction if they had been located extracellularly. In WCL of the HA-
ΔMCT strain that also contains the ΔsphB1 deletion, more unprocessed FhaB protein was
detected, as well as a polypeptide of about 230 kDa, which is presumably a product of
cleavage by the unidentified protease(s) (Figure 6B, bands 11 and 12, respectively). No
polypeptides of any size were detected by either antibody in supernatant fractions of the
HA-ΔMCT strain, regardless of whether sphB1 was wildtype or deleted, indicating that the
MCT is required for FHA release. The MCT, therefore, is required for release of FHA, but
not for intracellular retention of the prodomain.
In the HA-ΔPNT strain, FhaB was extensively processed, resulting in the formation of
several polypeptides of around 250 kDa (Figure 6B, bands 13). The processing was SphB1-
dependent as only full-length FhaB, which was recognized by both the anti-MCD and anti-
HA antibodies, was present in WCL of the HA-ΔPNT strain that also contained the ΔsphB1
deletion (Figure 6B, band 14). The HA-ΔPNT strain released a large amount of ~250 kDa
polypeptides that were recognized by only the anti-MCD antibody and lower molecular
weight (~50–100 kDa) polypeptides that were recognized only by the anti-HA antibody, into
the culture supernatant (Figure 6C, bands 4 and 5, respectively). The HA-ΔPNT strain with
the ΔsphB1 deletion released a large amount of full-length protein that was recognized by
both antibodies (Figure 6C, band 6). These results indicate that sequences within the PNT
are required for retention of the C-terminus of the prodomain in an intracellular
compartment and are not required for release of FhaB/FHA from the cell surface. In fact, the
HA-ΔPNT strain releases more FhaB/FHA from the surface than the wildtype strain,
suggesting that the PNT influences FHA release in a negative manner.
To further investigate the location of the prodomain in the HA-ΔMCT and HA-ΔPNT
strains, we performed dot blots (Figure 7). In the HA-ΔMCT strain (sphB1WT), only the
MCD, and not the HA epitope, was detected on the surface of whole cells (Figure 7B; note
that as with Fig. 5B, the schematics below the dot blots indicate only the various polypeptide
species, not their relative abundances). Lysing these cells resulted in detection of the HA
tag, indicative of an intracellular prodomain C-terminus. Whole cells of the ΔMCTΔsphB1
strain were detected at a low level by the anti-HA antibody, suggesting that some prodomain
C-terminus was surface-localized. This result suggests that lack of the MCT can overcome,
to some extent, the ability of the PNT to block translocation of the prodomain through FhaC
to the cell surface. If so, then in the ΔMCT strain that is wildtype for sphB1, the small
amount of prodomain that is translocated to the surface would be cleaved in an SphB1-
dependent manner and released into the supernatant. Indeed, a closer analysis of
concentrated supernatants revealed that the ΔMCT strain released cleaved prodomain
polypeptides, albeit much less efficiently than the ΔCS and ΔPNT strains (Supplemental
Figure 5B). Boiling the ΔMCTΔsphB1 strain increased detection by the anti-HA antibody,
indicating that although some prodomain crossed the outer membrane, most of it was
retained intracellularly.
In the HA-ΔPNT strain (sphB1WT), no HA epitopes were detected on the surface of whole-
cells (Figure 7B), consistent with the previous observation of extensive SphB1-dependent
cleavage of surface-localized prodomain (which was also observed in the HA-ΔCS strain).
Boiling these cells resulted in weak detection of the HA tag, which, as with the HA-ΔCS
strain, likely represents FhaB prior to translocation across the outer membrane. In the HA-
ΔPNT,ΔsphB1 strain, both the anti-MCD and the anti-HA antibodies were able to detect
surface protein, consistent with the prodomain crossing the outer membrane but not being
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cleaved in the absence of SphB1. Collectively, these data implicate to the PNT as the
subdomain responsible for intracellular localization of the prodomain C-terminus.
Discussion
The experiments described in this work yielded two primary findings: 1) the FhaB
prodomain remains in an intracellular compartment during FHA biogenesis and 2) the
prodomain affects the conformation of the FHA MCD. Our results also show that sequences
within the C-terminal half of the MCD (the MCT) are required for FHA to be released from
the cell surface and that sequences at the N-terminus of the prodomain (the PNT) are
required for the C-terminus of the prodomain to be retained intracellularly. Based on these
results, we propose a revised model for secretion by the FhaB-subfamily of TPS systems.
The revisions relate primarily to events occurring after the β-helical shaft has been exported
to the cell surface (Figure 8). The model states that as the MCT is secreted, FhaC changes
from a release-incompetent state to a release-competent state (the shift in FhaC release
competency is indicated in Figure 8 by a change in FhaC color from red to green).
Subsequent FhaB transit through FhaC is halted by the PNT, which we postulate folds into a
conformation that is incompatible with translocation. According to this model, the
prodomain functions as a tether that constrains the conformations that the extracellularly-
located MCD may sample while folding into a functional structure. Alternatively, the
prodomain may control the rate of translocation of the MCD, with rate-limited translocation
being required for the MCD to fold properly. We hypothesize that upon achieving a
functional conformation, the MCD signals maturation-cleavage readiness, resulting in FhaB
cleavage by the unidentified protease(s). The prodomain is rapidly degraded and additional
SphB1-dependent processing occurs. Fully matured FHA is then released into the
extracellular environment by an, as yet, unknown mechanism.
We reported previously that the prodomain is required for FHA function in vivo and we also
provided evidence that the MCD is an important functional domain, if not the functional
domain, of FHA during infection (Mazar and Cotter, 2006; Julio et al., 2009). In this study
we used semi-native PAGE, proteinase-K digestion, and cysteine residue accessibility
experiments to determine that the FhaB prodomain affects the conformation of the MCD.
These results indicate that the prodomain functions as an intramolecular chaperone that
controls the folding of the MCD. Proteinase-K digestion and dot blot experiments
demonstrated that the prodomain remains intracellular while the MCD is extracellular, but
they did not reveal whether the C-terminus of the prodomain remains in the cytoplasm or the
periplasm. Regardless of its exact intracellular location, the FhaB intramolecular chaperone
domain (the prodomain) and the functional domain it controls (the MCD) are separated by at
least one membrane. Although intramolecular chaperones that affect the conformation of
functional domains have been described, they typically co-localize with their functional
domains, acting as molecular scaffolds that guide the folding of the active domain of the
mature protein via direct protein-protein interactions. The best-characterized example of this
family of intramolecular chaperones is subtilisin E of B. subtilis (Shinde and Thomas,
2011). The FhaB prodomain appears to function in an entirely different manner since it does
not co-localize with the conformationally mature MCD. The simplest model is that the
prodomain, via its intracellular location, functions as a tether that constrains the folding
space of the MCD such that its functional conformation is the preferred fold amongst those
available for sampling. Although a more complex scenario, it is also possible that the FhaB
prodomain, either directly or indirectly from inside the cell, influences the translocation rate
of the MCD such that the MCD is translocated across the outer membrane in a manner
compatible with its proper folding on the cell surface. To our knowledge, neither of these
mechanisms for the control of protein folding has been described previously. However, a
similar concept has been described in the case of the E. coli autotransporter EspP. In this
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case, it is hypothesized that, prior to cleavage by leader peptidase, a cytoplasmically-located
extended signal peptide alters the conformation of the periplasmically-located β-domain
and, consequently, its ability to integrate into the outer membrane (Szabady et al., 2005).
Our experiments identified the PNT as the subdomain responsible for intracellular retention
of the prodomain. One mechanism by which the PNT may mediate intracellular prodomain
retention is by folding into a conformation incompatible with translocation through FhaC
(Figure 8). Alternatively, the PNT may interact with another molecule or molecular complex
that prevents export through FhaC. Whatever the mechanism, because this subdomain is
conserved amongst TpsA proteins of the FHA subfamily, intracellular retention of C-
terminal prodomains and the mechanism by which PNTs function may also be conserved.
As suggested by our model, we do not believe that the only role for the prodomain is to
function as a tether (if the tether hypothesis is even correct). We showed previously that a B.
bronchiseptica strain that produces an FhaB protein lacking only the C-terminal 339 aa (and
hence containing an intact PNT) is defective for tracheal colonization in a rats (Mazar and
Cotter, 2006) and we showed in this work that insertion of an HA epitope near the extreme
C-terminus of FhaB resulted in an inability to detect full-length FhaB, suggesting the
importance of this region for protein stability and/or resistance to protease digestion. These
data provide evidence that sequences C-terminal to the PNT are required for prodomain
function. We and others have also noted the presence of a proline rich region near the C-
terminus of the prodomain, but the role of this region is currently unknown. We hypothesize
that proper folding of the MCD on the cell surface is somehow sensed by the prodomain to
trigger continued FHA maturation (i.e., to stimulate cleavage and degradation of the
prodomain and then release of mature FHA). This would occur regardless of whether the
prodomain functions as a tether or a translocation rate limiter and we hypothesize that
regions of the prodomain C-terminal to the PNT are important for these steps in FHA
biogenesis. If the prodomain functions as a limiter of MCD translocation rate, then
sequences C-terminal to the PNT may also be involved in somehow controlling the rate of
translocation through FhaC, possibly by transiently influencing the conformation of the
MCD in the periplasm. Our future studies will be aimed at testing these hypotheses.
Although SphB1-independent proteolysis of FhaB to yield FHA* and FHA’ was apparent in
previous studies (Coutte et al., 2001; Mazar and Cotter, 2006), this cleavage was considered
‘aberrant’ and occurring primarily in the absence of SphB1 (Coutte et al., 2001). In this
work, we observed two circumstances in which prodomain polypeptides were generated that
were not cleaved by the unidentified protease. In each case, the prodomain polypeptides
were stable. The first instance was after proteinase-K digestion of the HAPRR strain
(sphB1WT and ΔsphB1). The second was in the ΔMCT strain, in which FhaB underwent
SphB1-dependent cleavage, but not SphB1-independent proteolysis. The fact that stable
prodomain polypeptides were present in both of these cases, despite the fact that they were
localized intracellularly and hence presumably accessible to the unidentified protease(s),
suggests that the unidentified protease(s) is responsible for degradation of the prodomain
and that it does so only in response to the normal sequence of events that occurs during
FhaB translocation and maturation. We speculate, therefore, that cleavage/degradation by
the unidentified protease(s) is an important regulated event during FHA biogenesis and we
are currently working to identify the protease(s), determine its spectrum of activity, and
understand how it is regulated.
While our results suggest a role for the unidentified protease(s), they failed to reveal an
important role for SphB1 with regard to FHA biogenesis. SphB1-dependent cleavage of
FhaB occurs at multiple locations and with varying efficiencies in wildtype B.
bronchiseptica and B. pertussis. Target promiscuity is especially evident in the HA-ΔCS
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strain, in which, despite a sizeable deletion surrounding the PLFETRIKFID region, SphB1-
dependent cleavage of FhaB occurred at alternate sites. Furthermore, the FhaB prodomains
in the HA-ΔCS and HA-ΔPNT strains reached the extracellular space, where they were
cleaved in an SphB1-dependent manner, suggesting that SphB1-dependent cleavage occurs
regardless of prodomain location. Although ΔsphB1 mutants of B. pertussis and B.
bronchiseptica are severely defective in mouse models of infection ((Coutte et al., 2003) and
our unpublished data), this virulence defect cannot be attributed solely to altered processing
of FhaB because SphB1-dependent cleavage of other Bordetella proteins occurs (our
unpublished data). It is also possible that SphB1 interacts with host cells in a manner
independent of its affects on other bacterial proteins. Understanding the roles SphB1 plays
in Bordetella biology, therefore, remains a challenging and currently unattained goal.
When grown in broth, B. pertussis and B. bronchiseptica release a substantial amount of
FHA into the culture medium. As FHA contributes to adherence of the bacteria to eukaryotic
cells in vitro more than any other Bordetella virulence factor (Relman et al., 1990; Cotter et
al., 1998; Mattoo et al., 2000), the fact that FHA is so efficiently released from the cell
surface has been perplexing. Recent data have indicated that FHA also functions to
modulate the inflammatory response (Inatsuka et al., 2005; Julio et al., 2009; Henderson et
al., 2012). Although in vitro studies suggest that the released form of FHA can affect host
cell signaling (McGuirk and Mills, 2000; Abramson et al., 2008; Dieterich and Relman,
2011), whether the released form of FHA plays an important role during infection is
unknown. The major obstacle to addressing this question is our current inability to construct
a strain that is defective only for FHA release. Previous studies with B. pertussis showed
that although short FHA molecules corresponding to the N-terminal ~30 and ~80 kDa of the
protein (the TPS domain and part of the β-helical shaft) were efficiently released into culture
supernatants, longer molecules that included most of the β-helical shaft or all of the β-
helical shaft plus the N-terminal half of the MCD were poorly released (Renauld-Mongenie
et al., 1996). If the initially synthesized FhaB polypeptide contained most of the prodomain,
however, mature FHA was efficiently released (Renauld-Mongenie et al., 1996). These data
suggest that sequences within the C-terminal half of the β-helical shaft render the system
incompetent for release and that sequences C-terminal to that region restore release
competency. Our experiments now reveal a critical role for the MCT in allowing FHA
release, suggesting that sequences within this region somehow cause the FhaB/FhaC
complex to switch from a release-incompetent to release-competent state. How this switch
might occur mechanistically is completely unknown, but we are optimistic that further
investigation will reveal an understanding to a level that will allow the construction of
strains that fail to release otherwise functional FHA proteins so that the role of FHA release
during infection can be investigated.
Although our results have provided insight into the mechanism of FHA secretion and
maturation, they also raise the question of why FHA maturation and release is so complex,
and they remind us that data obtained by studying bacteria in culture in the laboratory must
be interpreted with caution. During infection, Bordetella spp produce FHA while residing on
the mucosal surface of the respiratory tract. We and others have assumed that the “mature”
~250 kDa FHA protein is the functional form during infection. However, it is possible that
precleaved FhaB (currently considered a secretion intermediate) performs an important
biological role. Our data suggest that the prodomain confers tension across the outer
membrane, restraining mobility of the MCD, and we propose that once the MCD has folded,
conformational information may also be sent back across the membrane to trigger cleavage
and degradation of the prodomain by the unidentified protease(s). The potential for the
MCD to communicate signals across the outer membrane to the prodomain raises the
intriguing possibility that those signals could be generated in response to events that occur
during infection, such as binding to specific host cell receptors. Moreover, the possibility
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exists that those signals could affect processes in the bacterial cell in addition to those
related to FHA maturation, such as, perhaps, signal transduction and gene expression
changes. Our future studies will be aimed at testing these hypotheses.
Experimental Procedures
Bioinformatics
Proteins containing regions of similarity to the FhaB PNT were identified with a PSI-
BLAST search. ClustalW alignment was used to identify similar and identical residues
amongst the resulting TpsA proteins. WebLogo 3 was used for presentation of the ClustalW
alignment (Crooks et al., 2004).
Adherence assay
Adherence to rat lung epithelial cells (L2) was performed as described (Cotter et al., 1998).
Semi-native polyacrylamide gel analysis of FHA MCD
25 mL overnight cultures of BPSMAQ and BPSMAQT-N were grown to OD600 of 3–5.
Cultures were spun down at 11,000 rpm for 10 minutes at 4°C. Supernatants were collected
and sterilized using a Millex-GV syringe driven filter units by Millipore (0.22 μm PVDF). 2
ml of ProBond slurry were added to filter-sterilized supernatants and the mixes were
incubated end-over-end for one hour at room temperature. The slurry-supernatant mixes
were spun at 3,500 rpm for five minutes and supernatant set aside. The pelleted resin was
washed twice in Native Binding Buffer and twice in Native Washing Buffer. The pelleted
resin was then washed twice in 250 μL of Native Elution Buffer (500 mM Imidazole), with
each wash and the resin being saved for analysis. Samples can be stored overnight at 4°C.
Samples were resolved on 6% SDS-PAGE gel (10 μL loaded).
The gel was stained by coomassie blue to assess elution yields. The elution with the highest
FHA yield was dialyzed in 1 L sterile PBS pH 7.4 overnight at 4°C to remove excess
Imidazole. 20x TEV buffer, 1 μL (10 units) AcTEV protease and 1 mM DTT (final) were
added to dialyzed samples. Samples were incubated at 30°C for six hours. 250 μL of
ProBond resin were added to the samples and samples were incubated end-over-end
overnight at 4°C to remove N-terminal portion of TEV protease-cleaved FHA from the
supernatant, leaving behind cleaved MCD in the flow-through. 15 μL of the flow-through
sample was added to 15 μL of 2x Native Sample Buffer. Samples were incubated at room
temperature or 95°C for 5 minutes. Samples were resolved on 0.6% and 2.0% SDS-PAGE
gels.
Proteinase-K digest of purified MCD
For digest of native MCD, 100 ng of protein was digested with various concentrations of
proteinase-K (from 0 to 100 μg/mL) for 15 minutes at RT. 2x sample buffer was then added
to each digest. After boiling, samples were separated using SDS-PAGE, transferred to
nitrocellulose, and probed with the anti-MCD antibody. For digest of denatured/renatured
MCD, 1 μg of protein was incubated in 50 μL 6 M Guanidinium for 30 minutes at 50°C,
then raised to 1 mL with PBS and concentrated using 10 kDa MW cut-off centrifugation
filters. The sample was then resuspended in PBS and incubated for 30’ at 37°C, vortexing
consistently. Samples were then split, loading 1/10 of each sample into individual tubes and
digested with various concentrations of proteinase-K (from 0 to 100 μg/mL) for 15 minutes
at RT. 2x sample buffer was then added to each digest. After boiling, samples were
separated using SDS-PAGE, transferred to nitrocellulose, and probed with the anti-MCD
antibody. Densitometry analyses were performed using ImageJ (Schneider et al., 2012).
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Accessibility of cysteine substitutions in the MCD
Overnight cultures of RBX11, RBX11-T-N, their respective cysteine substitutions and
RBX20 were grown overnight. Cultures were spun down at 14,000 rpm for three minutes.
Supernatants were collected and sterilized with a 0.22 μm filter. Filter-sterilized
supernatants were the concentrated using a Microcon Ultracel YM-100, spun at 14,000 for
15 minutes until all supernatant had been concentrated. Columns were washed in 500 μL
sterile PBS, pH 7.4. 100 μL of PBS was added to the columns; the columns were then
inverted in the epindorf tube and spun to elute concentrated and washed supernatant protein.
Samples were brought to 10 mM DTT and incubated at room temperature for 30 minutes. 2
μL of 10 mM DyLight 680 Maleimide (1 mg in 100 μL DMF) was added to each sample to
bring them to 0.2 mM DyLight. Samples were incubated for two hours at room temperature.
4:1–2x Sample Buffer: 1M DTT was added to samples, which were resolved by SDS-PAGE
gel, transferred to nitrocellulose membrane and analyzed by western blot.
Immunoblotting
Whole cell lysates and concentrated supernatants were prepared from Bordetella cultures as
described (Mazar and Cotter, 2006). Samples were resolved by 5.0% and 8.0%
polyacrylamide gels (2.0% SDS) as indicated in results section. For anti-MCD
immunodetection, IRDye 800CW Goat anti-Rabbit IgG (H + L) was used (Li-cor, diluted
1:25,000). For anti-HA immunodetection, IRDye 680LT Goat anti-Mouse IgG (H + L) was
used (Li-Cor, diluted 1:15,000). For anti-BvgS immunodetection, IRDye 800CW Goat anti-
Mouse IgG (H + L) was used (Li-Cor, diluted 1:25,0000). Membranes imaged on a Li-Cor
Odyssey infrared imaging system.
Proteinase-K digestion of FhaB
B. bronchiseptica cultures were grown to an OD600 of 1.5 to 3.0. Three samples per strain of
2 OD units were spun at 5000 rpm for ten minutes at 4°C to pellet bacteria. Supernatants
were aspirated and pellets were suspended to 200 μL cold HEPES buffer, pH 7.4. Samples
were spun at 5000 rpm for five minutes at 4°C and supernatants were aspirated. 200 μL of
mock reaction buffer (HEPES, pH 7.4), 1.0 μg/mL proteinase-K (Sigma-Aldrich) in
HEPES, or 1.0 μg/mL proteinase-K with 1 mM PMSF (MP Biomedicals) in HEPES were
added to each of the three samples per strain. Reactions proceeded for 30 minutes at 16°C. 2
μL of PMSF (1 mM final) were added to proteinase-K digested samples to neutralize
digestion. All samples were spun at maximum speed for one minute at room temperature
and supernatants were aspirated. Whole-cell lysates were prepared, resolved and
immunoblotted as described.
Dot blot analysis
B. bronchispetica cultures were grown to an OD600 of 2.0 to 4.0. Volumes equivalent to 2
OD units were spun at max speed for one minute to pellet bacteria. Supernatants were
aspirated and pellets were washed in PBS. Samples were spun again at max speed for one
minute and the wash was aspirated. Samples were suspended in 1 mL of PBS and split into
500 μL aliquots. Bacteria in one tube were boiled for five minutes to lyse cells. Intact and
lysed cells in were spotted (50 μL) onto a nitrocellulose membrane using a Whatman®
Minifold® I 96 well slot-blot array system. The membrane was blocked in 5% milk-PBS for
one hour. Immunodetection by anti-MCD and anti-HA primary antibodies and goat anti-
rabbit and goat anti-mouse secondary antibodies proceeded as described (here and (Mazar
and Cotter, 2006)).
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The FhaB prodomain affects the conformation of the MCD. (A) At top is an illustration of
mature FHA with an N-teriminal hexahistadine tag and a TEV protease cleavage site
upstream of the MCD. Below are schematics of the B. pertussis FhaB proteins as initially
synthesized. From left, the domains illustrated are the signal peptide (purple), the TPS
domain (orange), the β-helical shaft (light blue), the MCD (green), the PNT (dark red), and
the remainder of the prodomain (red). The hexahistadine tag is located between the signal
peptide and the TPS domain. The TEV protease cleavage site is located between the β-helix
and the MCD. The approximate site of SphB1-dependent cleavage is noted. The proline-rich
region (PRR) of the prodomain is also noted. Residue numbering is based on the B. pertussis
FhaB protein. (B) The strains were tested to determine if the hexahistadine tag and TEV
protease site altered FHA mediated adherence to A549 human lung epithelial cells.
BPSMAQ adhered in a manner indistinguishable from wildtype B. pertussis, while
BPSMAQT-N adhered as inefficiently as an fhaB deletion strain. (C) Anti-MCD
immunoblot of purified MCD polypeptides. Semi-native gel analysis indicated altered
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mobility of the MCD derived from the prodomain-truncated (T-N) FhaB compared to the
MCD derived from full-length (AQ) FhaB. When denatured by either heat or chemical
denaturation, the MCDs of both proteins migrate identically. (D) Western blot of MCD
polypeptides after proteinase-K treatment. Purified MCDs were tested for sensitivity to
proteinase-K. Samples were incubated with increasing concentrations of proteinase-K,
separated by SDS-PAGE, and detected with anti-MCD antibody. Additionally, samples were
denatured/renatured prior to analysis of proteinase- K sensitivity. Densitometery values
proportionate to the undigested sample of each Western blot are listed below the blots.
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The FhaB prodomain affects the surface-accessibility of MCD residues. (A) Schematic of B.
bronchiseptica FhaB cysteine-substitution proteins. Single cysteine residues were substituted
into wildtype (WT) and prodomain-truncated (ΔPD) proteins. (B) Cysteine-accessibility
immunoblot of FHA recovered under native conditions from culture supernatants. The
Western blots were immuno-stained with an anti-CRD antibody and displayed four isoforms
of mature, released FHA. Native FHA was incubated with DyLight 680 Maleimide prior to
SDS-PAGE.
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The C-terminus of the prodomain resides intracellularly during FHA maturation. (A)
Schematic of B. bronchiseptica HA-tagged FhaB protein used in proteinase-K digestion
experiments. The site of the HA tag is noted. (B) Left, anti-MCD and anti-HA immunoblot
of proteinase-K treated whole-cells, lysed to evaluate cellular protein content. PMSF was
added prior to proteinase-K incubation as indicated. The panel on the right is an analysis of
the immunoblot on left, with the intensity of the 700 nm (anti-HA) channel increased for
visualization of proteinase-K dependent intracellular prodomain. Bottom, anti-BvgS
immunoblot of whole-cell lysates.
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The region surrounding the native SphB1-dependent cleavage site regulates FHA release
and keeps the C-terminus of the prodomain intracellular. (A) Schematic of proteins used in
proteinase-K digestion experiments. (B) Top, anti-MCD and anti-HA immunoblot of whole-
cell lysate of the cleavage-site deletion strain. Cells were incubated with proteinase-K as
indicated. PMSF was added prior to proteinase-K incubation as indicated. Numbers above
protein bands correspond to illustrations on the right side of the figure. Illustrations 1–4
represent products of the HAPRR strain, while illustrations 5–9 represent products of the
HA-ΔCS strain. These illustrations show how we envision FhaB/FhaC exist at the outer
membrane (OM, gray), with the area above the OM representing the extracellular space and
the region below the OM representing the intracellular space. Proteinase-K is colored
orange. Illustrations are not drawn to scale. Bottom, anti-BvgS immunoblot of whole-cell
lysates. (C) Anti-MCD and anti-HA immunoblot of concentrated supernatants. Samples
were run on an 8% polyacrylamide gel to resolve the released forms of FHA and prodomain.
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The prodomain C-terminus of full-length FhaB remains intracellular. (A) Schematic of
proteins used in dot blot experiments. (B) At the top, anti-MCD and anti-HA immuno-dot-
blot of HAPRR and HA-ΔCS strains. Normalized amounts of whole cells and boiled lysates
were applied. Below, illustrations of immuno-stained samples. The rounded gray rectangle
represents the B. bronchiseptica outer membrane, with a solid edge representing the outer
membrane of an intact cell and a dashed edge representing an outer membrane disrupted by
boiling. MCD staining is represented by green-circled antibodies and HA staining is
represented by red-circled antibodies.
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The MCT controls FHA release and the PNT keeps the prodomain C-terminus intracellular.
(A) Schematic of FhaB proteins used in experiment. The MCT is represented as dark green.
(B) Anti-MCD and anti-HA immunoblot of whole-cell lysates. Numbers above protein
bands correspond to illustrations on the right side of the figure. Illustrations 1–4 represent
products of the HAPRR strain, 5–7 represent products of the HA-ΔCS strain, 8–12 represent
products of the HA-ΔMCT strain, and 13 and 14 represent products of the HA-ΔPNT strain.
Layout of these illustrations is as described in Figure 4B. (C) Anti-MCD and anti-HA
immunoblot of concentrated supernatants. Numbers above protein bands correspond to
illustrations on the right side of the figure. Illustrations 1 and 2 represent products of the
HAPRR strain, 3 represents the product of the HA-ΔCS strain, and 4–6 represent products
of the HA-ΔPNT strain. Layout of these illustrations is as described in Figure 4B. Deletion
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of the MCT prevents FHA release, while deletion of the PNT promotes release.
Additionally, deletion of the PNT results in translocation of the prodomain into the
extracellular space where it can be separated from FHA in an SphB1-dependent manner.
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The prodomain of the HA-ΔMCT strain is mostly intracellularly-localized while that of the
HA-ΔPNT strain is extracellularly-localized. (A) Schematic of proteins used in dot blot
experiments. (B) At the top, anti-MCD and anti-HA immuno-dot-blot of HAPRR, HA-
ΔMCT and HA-ΔPNT strains. Normalized amounts of whole cells and boiled lysates were
applied. Below, illustrations of immuno-stained samples. Layout of these illustrations is as
described in Figure 5B.
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Revised model for FHA biogenesis. Our model continues from Supplemental Figure 1A,
with the β-helix surface-localized and the MCD and prodomain still inside the cell. During
the secretion process, the PNT adopts a conformation that prevents prodomain transit
through FhaC. Next, the MCT of FhaB translocates to the extracellular space, priming FhaC
for release of FHA, as indicated by the shift in FhaC color from red to green. The
translocation-impaired PNT confers tension across the extracellular space to the MCD,
restricting the conformations the MCD may sample while folding. FhaB undergoes
maturation into FHA upon completion of MCD folding, with FHA maturation being
accomplished by SphB1-independent cleavage, degradation of the prodomain and SphB1-
dependent cleavage. At this point, FHA is fully mature and can remain either surface-
associated or be released into the supernatant.
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